Bone morphogenetic proteins in orthopaedic surgery

Cheng, 2003, Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs), J Bone Joint Surg Am, 85-A, 1544, 10.2106/00004623-200308000-00017 Rankin, 2000, Regulation of left-right patterning in mice by growth/differentiation factor-1, Nat Genet, 24, 262, 10.1038/73472 Saito, 2008, Characterization of the post-translational modification of recombinant human BMP-15 mature protein, Protein Sci, 17, 362, 10.1110/ps.073232608 Axelrad, 2007, New technologies for the enhancement of skeletal repair, Injury, 38, S49, 10.1016/j.injury.2007.02.010 Chang, 2002, Genetic analysis of the mammalian transforming growth factor-beta superfamily, Endocr Rev, 23, 787, 10.1210/er.2002-0003 Fairlie, 1999, MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation, J Leukoc Biol, 65, 2, 10.1002/jlb.65.1.2 Massague, 1998, TGF-beta signal transduction, Annu Rev Biochem, 67, 753, 10.1146/annurev.biochem.67.1.753 Tsuchida, 2008, Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer, Endocr J, 55, 11, 10.1507/endocrj.KR-110 Heldin, 1997, TGF-beta signalling from cell membrane to nucleus through SMAD proteins, Nature, 390, 465, 10.1038/37284 Hopkins, 2007, The bone morphogenetic protein 1/Tolloid-like metalloproteinases, Matrix Biol, 26, 508, 10.1016/j.matbio.2007.05.004 Amthor, 2009, Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity, Proc Natl Acad Sci U S A, 106, 7479, 10.1073/pnas.0811129106 Khan, 2009, Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction, Eur Heart J, 30, 1057, 10.1093/eurheartj/ehn600 Mazerbourg, 2003, Growth differentiation factor-9 signaling in the ovary, Mol Cell Endocrinol, 202, 31, 10.1016/S0303-7207(03)00058-3 Katoh, 2006, Comparative integromics on BMP/GDF family, Int J Mol Med, 17, 951 Andersson, 2007, Distinct and cooperative roles of mammalian Vg1 homologs GDF1 and GDF3 during early embryonic development, Dev Biol, 311, 500, 10.1016/j.ydbio.2007.08.060 Tsuji, 2006, BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing, Nat Genet, 38, 1424, 10.1038/ng1916 Aoki, 2001, Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction, J Cell Sci, 114, 1483, 10.1242/jcs.114.8.1483 Wutzl, 2006, Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation, J Biomed Mater Res A, 77, 75, 10.1002/jbm.a.30615 Ebisawa, 1999, Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation, J Cell Sci, 112, 3519, 10.1242/jcs.112.20.3519 Ozkaynak, 1992, Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis, J Biol Chem, 267, 25220, 10.1016/S0021-9258(19)74028-9 Zhao, 1996, Evidence that mouse Bmp8a (Op2) and Bmp8b are duplicated genes that play a role in spermatogenesis and placental development, Mech Dev, 57, 159, 10.1016/0925-4773(96)00543-6 Chang, 2001, Smad5 is required for mouse primordial germ cell development, Mech Dev, 104, 61, 10.1016/S0925-4773(01)00367-7 David, 2007, Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells, Blood, 109, 1953, 10.1182/blood-2006-07-034124 Neuhaus, 1999, Heart specific expression of mouse BMP-10 a novel member of the TGF-beta superfamily, Mech Dev, 80, 181, 10.1016/S0925-4773(98)00221-4 Lo, 2005, Late-emigrating neural crest cells in the roof plate are restricted to a sensory fate by GDF7, Proc Natl Acad Sci U S A, 102, 7192, 10.1073/pnas.0502581102 Furuya, 1999, Effects of GDF7/BMP12 on proliferation and alkaline phosphatase expression in rat osteoblastic osteosarcoma ROS 17/2.8 cells, J Cell Biochem, 72, 177, 10.1002/(SICI)1097-4644(19990201)72:2<177::AID-JCB2>3.0.CO;2-# Shen, 2009, BMP-13 emerges as a potential inhibitor of bone formation, Int J Biol Sci, 5, 192, 10.7150/ijbs.5.192 Dupoirieux, 2009, A preliminary report on the effect of dimeric rhGDF-5 and its monomeric form rhGDF-5C465A on bone healing of rat cranial defects, J Craniomaxillofac Surg, 37, 30, 10.1016/j.jcms.2008.08.004 Daluiski, 2001, Bone morphogenetic protein-3 is a negative regulator of bone density, Nat Genet, 27, 84, 10.1038/83810 Bahamonde, 2001, BMP3: to be or not to be a BMP, J Bone Joint Surg Am, 83-A, S56 Cho, 2002, Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing, J Bone Miner Res, 17, 513, 10.1359/jbmr.2002.17.3.513 Cunningham, 1995, Growth/differentiation factor-10: a new member of the transforming growth factor-beta superfamily related to bone morphogenetic protein-3, Growth Factors, 12, 99, 10.3109/08977199509028956 Clarke, 2001, Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression, Mol Endocrinol, 15, 946, 10.1210/me.15.6.946 Behringer, 1994, Mullerian-inhibiting substance function during mammalian sexual development, Cell, 79, 415, 10.1016/0092-8674(94)90251-8 Rankin, 2000, Regulation of left–right patterning in mice by growth/differentiation factor-1, Nat Genet, 24, 262, 10.1038/73472 Cheng, 2004, Lefty blocks a subset of TGFbeta signals by antagonizing EGF-CFC coreceptors, PLoS Biol, 2, E30, 10.1371/journal.pbio.0020030 Levine, 2006, GDF3 at the crossroads of TGF-beta signaling, Cell Cycle, 5, 1069, 10.4161/cc.5.10.2771 Laitinen, 1998, A novel growth differentiation factor-9 (GDF-9) related factor is co-expressed with GDF-9 in mouse oocytes during folliculogenesis, Mech Dev, 78, 135, 10.1016/S0925-4773(98)00161-0 Liao, 2003, Effect of intracellular interactions on the processing and secretion of bone morphogenetic protein-15 (BMP-15) and growth and differentiation factor-9. Implication of the aberrant ovarian phenotype of BMP-15 mutant sheep, J Biol Chem, 278, 3713, 10.1074/jbc.M210598200 Kaivo-Oja, 2003, Growth differentiation factor-9 induces Smad2 activation and inhibin B production in cultured human granulosa-luteal cells, J Clin Endocrinol Metab, 88, 755, 10.1210/jc.2002-021317 Xu, 2006, GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation, Circ Res, 98, 342, 10.1161/01.RES.0000202804.84885.d0 Rebbapragada, 2003, Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis, Mol Cell Biol, 23, 7230, 10.1128/MCB.23.20.7230-7242.2003 Sartori, 2009, Smad2 and 3 transcription factors control muscle mass in adulthood, Am J Physiol Cell Physiol, 296, C1248, 10.1152/ajpcell.00104.2009 Mottershead, 2008, Characterization of recombinant human growth differentiation factor-9 signaling in ovarian granulosa cells, Mol Cell Endocrinol, 283, 58, 10.1016/j.mce.2007.11.007 Guzman-Ayala, 2009, Graded Smad2/3 activation is converted directly into levels of target gene expression in embryonic stem cells, PLoS One, 4, e4268, 10.1371/journal.pone.0004268 Moore, 2003, Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells, J Biol Chem, 278, 304, 10.1074/jbc.M207362200 Zhan, 2006, Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression, Development, 133, 2359, 10.1242/dev.02383 Visser, 2001, The serine/threonine transmembrane receptor ALK2 mediates Mullerian inhibiting substance signaling, Mol Endocrinol, 15, 936, 10.1210/me.15.6.936 Kang, 2004, Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery, Gene Ther, 11, 1312, 10.1038/sj.gt.3302298 Ryaby, 2006, Thrombin peptide TP508 stimulates cellular events leading to angiogenesis, revascularization, and repair of dermal and musculoskeletal tissues, J Bone Joint Surg Am, 88, 132, 10.2106/JBJS.F.00892 Axelrad, 2007, New bio-technologies for the stimulation of bone repair, Giornale Italiano di Orthopedia E Traumatolgia, 33, S262 Diefenderfer, 2003, Regulation of BMP-induced transcription in cultured human bone marrow stromal cells, J Bone Joint Surg Am, 85-A, 19, 10.2106/00004623-200300003-00005 Schultz DG. P000058 letter of approval. 7-2-2002. Department of Health and Human Services, Center for Devices and Radiological Health. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf/P000058a.pdf. Accessed 8-4-2009. Schultz DG. P000054 letter of approval. 4-30-2004. Department of Health and Human Services, Center for Devices and Radiological Health. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf/p000054a.pdf. Accessed 8-4-2009. Schultz DG. P050053 letter of approval. 3-9-2007. Department of Health and Human Services, Center for Devices and Radiological Health. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf5/p050053a.pdf. Accessed 8-4-2009. Schultz DG. HDE H010002 letter of approval. 11-17-2001. Department of Health and Human Services, Center for Devices and Radiological Health. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf/h010002a.pdf. Accessed 8-4-2009. Schultz DG. HDE H020008 letter of approval. 5-7-2004. Department of Health and Human Services, Center for Devices and Radiological Health. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf2/H020008a.pdf. Accessed 8-4-2009. Tillman D. HDE H040004 letter of approval. 2008. Department of Health and Human Services, Center for Devices and Radiological Health. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf4/H040004a.pdf. Accessed 8-4-2009. Position Statement 1177. Off-label use of medical products. 6-1-2009. American Academy of Orthopaedic Surgeons, Rosemont, IL. Available at: http://www6.aaos.org/news/PDFopen/PDFopen.cfm?page_url=http://www.aaos.org/about/papers/position/1177.asp. Accessed 8-4-2009. Adams, 2001, Cigarette smoking and open tibial fractures, Injury, 32, 61, 10.1016/S0020-1383(00)00121-2 Gruber, 2006, Fracture healing in the elderly patient, Exp Gerontol, 41, 1080, 10.1016/j.exger.2006.09.008 Garvin, 2007, Does the number or quality of pluripotent bone marrow stem cells decrease with age?, Clin Orthop Relat Res, 465, 202, 10.1097/BLO.0b013e318159a9b8 Makino, 2005, Prevention of atrophic nonunion development by recombinant human bone morphogenetic protein-7, J Orthop Res, 23, 632, 10.1016/j.orthres.2004.09.009 Friedlaender, 2001, Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions, J Bone Joint Surg Am, 83-A, S151 Bong, 2005, Osteogenic protein-1 (bone morphogenic protein-7) combined with various adjuncts in the treatment of humeral diaphyseal nonunions, Bull Hosp Jt Dis, 63, 20 Giannoudis, 2007, Biological enhancement of bone healing with bone morphogenetic protein-7 at the clinical setting of pelvic girdle non-unions, Injury, 38, S43, 10.1016/S0020-1383(08)70008-1 Reckling, 1980, Treatment of non-unions of fractures of the tibial diaphysis by posterolateral cortical cancellous bone-grafting, J Bone Joint Surg Am, 62, 936, 10.2106/00004623-198062060-00009 Phieffer, 2006, Delayed unions of the tibia, J Bone Joint Surg Am, 88, 206, 10.2106/00004623-200601000-00026 Giannoudis, 2009, The synergistic effect of autograft and BMP-7 in the treatment of atrophic nonunions, Clin Orthop Relat Res, 10.1007/s11999-009-0846-2 Ring, 2005, Treatment of osteoporotic distal radius fractures, Osteoporos Int, 16, S80, 10.1007/s00198-004-1808-x Ekrol, 2008, A comparison of RhBMP-7 (OP-1) and autogenous graft for metaphyseal defects after osteotomy of the distal radius, Injury, 39, S73, 10.1016/S0020-1383(08)70018-4 Vaccaro, 2004, A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis, Spine (Phila Pa 1976), 29, 1885, 10.1097/01.brs.0000137062.79201.98 Vaccaro, 2005, A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions, Eur Spine J, 14, 623, 10.1007/s00586-004-0845-7 Vaccaro, 2005, Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study, Spine (Phila Pa 1976), 30, 2709, 10.1097/01.brs.0000190812.08447.ba Furlan, 2007, Use of osteogenic protein-1 in patients at high risk for spinal pseudarthrosis: a prospective cohort study assessing safety, health-related quality of life, and radiographic fusion. Invited submission from the Joint Section on Disorders of the Spine and Peripheral Nerves, March 2007, J Neurosurg Spine, 7, 486, 10.3171/SPI-07/09/486 Wang, 1990, Recombinant human bone morphogenetic protein induces bone formation, Proc Natl Acad Sci U S A, 87, 2220, 10.1073/pnas.87.6.2220 Sciadini, 2000, Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model, J Orthop Res, 18, 289, 10.1002/jor.1100180218 Einhorn, 2003, A single percutaneous injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair, J Bone Joint Surg Am, 85-A, 1425, 10.2106/00004623-200308000-00002 Govender, 2002, Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients, J Bone Joint Surg Am, 84-A, 2123, 10.2106/00004623-200212000-00001 Swiontkowski, 2006, Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies, J Bone Joint Surg Am, 88, 1258, 10.2106/JBJS.E.00499 Bosse, 2002, An analysis of outcomes of reconstruction or amputation after leg-threatening injuries, N Engl J Med, 347, 1924, 10.1056/NEJMoa012604 Bhandari, 2008, Randomized trial of reamed and unreamed intramedullary nailing of tibial shaft fractures, J Bone Joint Surg Am, 90, 2567, 10.2106/JBJS.G.01694 Henley, 1998, Treatment of type II, IIIA, and IIIB open fractures of the tibial shaft: a prospective comparison of unreamed interlocking intramedullary nails and half-pin external fixators, J Orthop Trauma, 12, 1, 10.1097/00005131-199801000-00001 Joshi, 2004, Unreamed interlocking nailing in open fractures of tibia, J Orthop Surg (Hong Kong), 12, 216, 10.1177/230949900401200215 Kim, 2009, Prospective study of iliac crest bone graft harvest site pain and morbidity, Spine J, 9, 886, 10.1016/j.spinee.2009.05.006 Carreon, 2009, RhBMP-2 versus iliac crest bone graft for lumbar spine fusion in patients over 60 years of age: a cost-utility study, Spine (Phila Pa 1976), 34, 238, 10.1097/BRS.0b013e31818ffabe Sengupta, 2006, Outcome of local bone versus autogenous iliac crest bone graft in the instrumented posterolateral fusion of the lumbar spine, Spine (Phila Pa 1976), 31, 985, 10.1097/01.brs.0000215048.51237.3c Boden, 2002, Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies, Spine (Phila Pa 1976), 27, 2662, 10.1097/00007632-200212010-00005 Burkus, 2005, Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery, J Bone Joint Surg Am, 87, 1205, 10.2106/JBJS.D.02532 Acosta, 2009, Patient satisfaction and radiographic outcomes after lumbar spinal fusion without iliac crest bone graft or transverse process fusion, J Clin Neurosci, 16, 1184, 10.1016/j.jocn.2008.12.006 Dawson, 2009, Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial, J Bone Joint Surg Am, 91, 1604, 10.2106/JBJS.G.01157 HDE H040004 FDA Summary of Saftey and Probable Benefit. 2009. Department of Health and Human Services, Center for Devices and Radiological Health. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf4/H040004b.pdf. Accessed 8-4-2009. Allen, 2007, Bone morphogenetic protein-2 (BMP-2) in the treatment of pyogenic vertebral osteomyelitis, Spine (Phila Pa 1976), 32, 2996, 10.1097/BRS.0b013e31815cde3e Buttermann, 2008, Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion, Spine J, 8, 426, 10.1016/j.spinee.2006.12.006 Shields, 2006, Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion, Spine (Phila Pa 1976), 31, 542, 10.1097/01.brs.0000201424.27509.72 Smucker, 2006, Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine, Spine (Phila Pa 1976), 31, 2813, 10.1097/01.brs.0000245863.52371.c2 Vaidya, 2007, Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2, Eur Spine J, 16, 1257, 10.1007/s00586-007-0351-9 Lewandrowski, 2007, Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases, Spine J, 7, 609, 10.1016/j.spinee.2007.01.011 Joseph, 2007, Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis, Spine (Phila Pa 1976), 32, 2885, 10.1097/BRS.0b013e31815b7596 Brower, 2008, A case of psoas ossification from the use of BMP-2 for posterolateral fusion at L4–L5, Spine (Phila Pa 1976), 33, E653, 10.1097/BRS.0b013e31817c4f1c Wysocki, 2007, Ectopic ossification of the triceps muscle after application of bone morphogenetic protein-7 to the distal humerus for recalcitrant nonunion: a case report, J Hand Surg Am, 32, 647, 10.1016/j.jhsa.2007.03.001 Axelrad, 2008, Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients, J Bone Joint Surg Br, 90, 1617, 10.1302/0301-620X.90B12.20975 Cahill, 2009, Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures, JAMA, 302, 58, 10.1001/jama.2009.956